14/06/2015 - 14:07
ROME – Many patients with rheumatoid arthritis can reduce – or even discontinue – their
maintenance therapy with tumor necrosis factor inhibitors after they achieve clinical stability.
Half who...
Field of Interest: Rheumatology
Categories:
News Feed: Internal Medicine News - Rheumatology